Institutional Ownership Protalix Bio Therapeutics, Inc. (PLX)
This table provides information about the institutional ownership of Protalix Bio Therapeutics, Inc. (PLX). We have compiled data on the 70 institutions that hold shares in the stock, with a total of 8.27 Million shares, which have been reported (via 13F filing form) to have a value of $12 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
May 14, 2025 Q1 2025 |
1,188,953
shares
|
$1.72 Million
0.0% of portfolio
|
Q1 2025
Added 6.35%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
May 15, 2025 Q1 2025 |
963,011
shares
|
$1.4 Million
0.0% of portfolio
|
Q1 2025
Added 148.25%
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
May 14, 2025 Q1 2025 |
858,650
shares
|
$1.25 Million
0.0% of portfolio
|
Q1 2025
New holding
|
|
Northern Trust Corp
Chicago, IL |
May 13, 2025 Q1 2025 |
684,758
shares
|
$992,899
0.0% of portfolio
|
Q1 2025
Reduced 6.42%
|
|
Marshall Wace, LLP
London, X0 |
May 15, 2025 Q1 2025 |
615,085
shares
|
$891,873
0.0% of portfolio
|
Q1 2025
Added 503.62%
|
|
Connor, Clark & Lunn Investment Management Ltd.
|
May 12, 2025 Q1 2025 |
482,875
shares
|
$700,168
0.01% of portfolio
|
Q1 2025
New holding
|
|
Stratos Wealth Partners, Ltd.
|
Apr 30, 2025 Q1 2025 |
346,400
shares
|
$502,280
0.01% of portfolio
|
Q1 2025
Added 28.3%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
333,171
shares
|
$483,097
0.0% of portfolio
|
Q2 2024
Reduced 89.94%
|
|
Jane Street Group, LLC
New York, NY |
May 19, 2025 Q1 2025 |
294,318
shares
|
$426,761
0.0% of portfolio
|
Q1 2025
Added 159.05%
|
|
Goldman Sachs Group Inc
New York, NY |
Jun 26, 2025 Q1 2025 |
289,461
shares
|
$419,718
0.0% of portfolio
|
Q1 2025
Added 482.3%
|
|
Gsa Capital Partners LLP
London, X0 |
May 08, 2025 Q1 2025 |
209,292
shares
|
$303,473
0.05% of portfolio
|
Q1 2025
Reduced 31.55%
|
|
Bridgeway Capital Management, LLC
Houston, TX |
May 15, 2025 Q1 2025 |
189,100
shares
|
$274,195
0.01% of portfolio
|
Q1 2025
Added 4.24%
|
|
Omers Administration Corp
Toronto, A6 |
May 14, 2025 Q1 2025 |
179,300
shares
|
$259,985
0.0% of portfolio
|
Q1 2025
New holding
|
|
Schonfeld Strategic Advisors LLC
New York, NY |
May 15, 2025 Q1 2025 |
163,058
shares
|
$236,434
0.0% of portfolio
|
Q1 2025
New holding
|
|
Squarepoint Ops LLC
New York, NY |
May 15, 2025 Q1 2025 |
120,786
shares
|
$175,139
0.0% of portfolio
|
Q1 2025
Added 63.36%
|
|
Qube Research & Technologies LTD
London, X0 |
May 15, 2025 Q1 2025 |
118,808
shares
|
$172,271
0.0% of portfolio
|
Q1 2025
Added 377.77%
|
|
Hillsdale Investment Management Inc.
Toronto, A6 |
May 09, 2025 Q1 2025 |
116,100
shares
|
$168,345
0.02% of portfolio
|
Q1 2025
New holding
|
|
Two Sigma Investments, LP
New York, NY |
May 15, 2025 Q1 2025 |
86,354
shares
|
$125,213
0.0% of portfolio
|
Q1 2025
New holding
|
|
Morgan Stanley
New York, NY |
May 15, 2025 Q1 2025 |
83,558
shares
|
$121,159
0.0% of portfolio
|
Q1 2025
Reduced 50.91%
|
|
Jain Global LLC
New York, NY |
May 15, 2025 Q1 2025 |
81,963
shares
|
$118,846
0.0% of portfolio
|
Q1 2025
New holding
|
|
Balyasny Asset Management LLC
Chicago, IL |
May 15, 2025 Q1 2025 |
76,063
shares
|
$110,291
0.0% of portfolio
|
Q1 2025
New holding
|
|
Point72 Asia (Singapore) Pte. Ltd.
Singapore, U0 |
May 15, 2025 Q1 2025 |
54,174
shares
|
$78,552
0.04% of portfolio
|
Q1 2025
Added 1.25%
|
|
Cubist Systematic Strategies, LLC
Stamford, CT |
May 15, 2025 Q1 2025 |
53,380
shares
|
$77,401
0.0% of portfolio
|
Q1 2025
Added 82.14%
|
|
Quantessence Capital LLC
New York, NY |
May 15, 2025 Q1 2025 |
51,243
shares
|
$74,302
0.03% of portfolio
|
Q1 2025
New holding
|
|
Commonwealth Equity Services, LLC
|
May 09, 2025 Q1 2025 |
50,025
shares
|
$72,536
0.0% of portfolio
|
Q1 2025
Added 0.05%
|